Cost-effectiveness analysis of a single-inhaler triple therapy for patients with advanced chronic obstructive pulmonary disease (COPD) using the FULFIL trial: A UK perspective

Respiratory Medicine X ◽

10.1016/j.yrmex.2019.100008 ◽

2019 ◽

Vol 1 ◽

pp. 100008

Author(s):

Melanie Schroeder ◽

Dhvani Shah ◽

Nancy Risebrough ◽

Alan Martin ◽

Shiyuan Zhang ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Cost Effectiveness ◽

Triple Therapy ◽

Pulmonary Disease ◽

Cost Effectiveness Analysis ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Effectiveness Analysis

Download Full-text

Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish Perspective

International Journal of Chronic Obstructive Pulmonary Disease ◽

10.2147/copd.s240556 ◽

2020 ◽

Vol Volume 15 ◽

pp. 1621-1632

Author(s):

Melanie Schroeder ◽

Nicole Benjamin ◽

Laura Atienza ◽

Chandroday Biswas ◽

Alan Martin ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Cost Effectiveness ◽

Triple Therapy ◽

Pulmonary Disease ◽

Cost Effectiveness Analysis ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Effectiveness Analysis

Download Full-text

PRS31 THE IMPACT TRIAL: COST-EFFECTIVENESS ANALYSIS OF SINGLE-INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS DUAL BRONCHODILATOR THERAPY (UMEC/VI) IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN SPAIN

Value in Health ◽

10.1016/j.jval.2019.09.2521 ◽

2019 ◽

Vol 22 ◽

pp. S878

Author(s):

L.A. Vallejo-Aparicio ◽

V.F. Paly ◽

M. Schroeder ◽

A. Martin ◽

N. Risebrough ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Cost Effectiveness ◽

Triple Therapy ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Bronchodilator Therapy ◽

Effectiveness Analysis ◽

Download Full-text

Cost-Effectiveness Analysis Of A Pharmacist-Led Intervention On Improving Inhaler Adherence In Patients With Chronic Obstructive Pulmonary Disease

Value in Health ◽

10.1016/j.jval.2014.03.788 ◽

2014 ◽

Vol 17 (3) ◽

pp. A136

Author(s):

JF van Boven ◽

E Tommelein ◽

K Boussery ◽

E Mehuys ◽

S Vegter ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Cost Effectiveness Analysis ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Effectiveness Analysis

Download Full-text

Cost-Effectiveness Analysis of Glycopyrronium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease in Spain

Value in Health ◽

10.1016/j.jval.2013.08.287 ◽

2013 ◽

Vol 16 (7) ◽

pp. A372 ◽

Author(s):

C. Torres ◽

I. Betoret ◽

E. Sabater ◽

M. Figueras ◽

M.A. Casado

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Cost Effectiveness Analysis ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Glycopyrronium Bromide ◽

Effectiveness Analysis

Download Full-text

Clinical Trial-Based Cost-Effectiveness Analysis of Indacaterol (ONBREZ® 150 MCG) Versus Tiotropium (SPIRIVA®) in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) IN TURKEY

Value in Health ◽

10.1016/j.jval.2014.08.2011 ◽

2014 ◽

Vol 17 (7) ◽

pp. A588

Author(s):

M. Saylan ◽

V. Beykoz ◽

A. Keskinaslan

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Clinical Trial ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Cost Effectiveness Analysis ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Effectiveness Analysis

Download Full-text

Evaluating the cost-effectiveness of combination inhalers for the management of chronic obstructive pulmonary disease

British Journal of Healthcare Management ◽

10.12968/bjhc.2020.0126 ◽

2020 ◽

Vol 26 (9) ◽

pp. 231-233

Author(s):

Matthew Taylor ◽

Michelle Green

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Cost Effectiveness Analysis ◽

Chronic Obstructive ◽

Valuable Insight ◽

Obstructive Pulmonary Disease ◽

Effectiveness Analysis ◽

The Cost ◽

Matthew Taylor and Michelle Green provide a valuable insight into methods of vital cost-effectiveness analysis of combination inhalers for the management of chronic obstructive pulmonary disease.

Download Full-text

Comparative Cost-effectiveness Analysis of Theophylline and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease

CHEST Journal ◽

10.1378/chest.103.3.678 ◽

1993 ◽

Vol 103 (3) ◽

pp. 678-684 ◽

Author(s):

Amal Jubran ◽

Nicholas Gross ◽

Joe Ramsdell ◽

Raffi Simonian ◽

Karl Schuttenhelm ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Ipratropium Bromide ◽

Cost Effectiveness Analysis ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Comparative Cost ◽

Effectiveness Analysis

Download Full-text

Cost-Effectiveness Analysis of Indacaterol/Glycopirronium (QVA149) as a Maintenance Bronchodilator Treatment in Adult Patients With Chronic Obstructive Pulmonary Disease in Spain

Value in Health ◽

10.1016/j.jval.2014.08.2066 ◽

2014 ◽

Vol 17 (7) ◽

pp. A598

Author(s):

M. Granell ◽

M. Giovanna ◽

S. Paz ◽

I. Betoret

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Cost Effectiveness Analysis ◽

Adult Patients ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Effectiveness Analysis ◽

Bronchodilator Treatment

Download Full-text

Improving inhaler adherence in patients with Chronic Obstructive Pulmonary Disease: a cost-effectiveness analysis

Respiratory Research ◽

10.1186/1465-9921-15-66 ◽

2014 ◽

Vol 15 (1) ◽

pp. 66 ◽

Author(s):

Job FM van Boven ◽

Eline Tommelein ◽

Koen Boussery ◽

Els Mehuys ◽

Stefan Vegter ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Cost Effectiveness Analysis ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Effectiveness Analysis

Download Full-text

PRS14 A COST-EFFECTIVENESS ANALYSIS ON THE USE OF INDACATEROL FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN MEXICO

Value in Health ◽

10.1016/j.jval.2011.02.775 ◽

2011 ◽

Vol 14 (3) ◽

pp. A139

Author(s):

B. Briones ◽

G. Zuñiga ◽

F. García-Contreras

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Cost Effectiveness Analysis ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Effectiveness Analysis

Download Full-text